PAVmed (PAVM) Share-based Compensation (2016 - 2025)

PAVmed's Share-based Compensation history runs 10 years deep, the most recent figure standing at -$970000.0 for Q4 2025.

• In Q4 2025, Share-based Compensation fell 232.33% year-over-year to -$970000.0; the TTM figure through Dec 2025 stood at $505000.0 (down 92.22% YoY), while the FY2025 annual figure was $505000.0, down 92.17% from the prior year.
• Share-based Compensation was -$970000.0 for Q4 2025 at PAVmed, down from $383000.0 in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $5.2 million in Q2 2021 to a low of -$970000.0 in Q4 2025.
• Historically, Share-based Compensation has averaged $2.7 million across 5 years, with a median of $2.2 million in 2023.
• The sharpest annual moves came in 2021 and 2025: Share-based Compensation jumped 883.55% in 2021, then plunged 232.33% in 2025.
• A 5-year view of Share-based Compensation shows it stood at $4.4 million in 2021, then rose by 12.99% to $4.9 million in 2022, then slumped by 60.23% to $2.0 million in 2023, then plunged by 62.75% to $733000.0 in 2024, then slumped by 232.33% to -$970000.0 in 2025.
• The last three Share-based Compensation figures came in at -$970000.0 (Q4 2025), $383000.0 (Q3 2025), and $162000.0 (Q2 2025), per Business Quant data.